• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经多参数磁共振成像检查,前列腺横截面积最大值可预测PI-RADS 3级病变中具有临床意义的前列腺癌。

Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging.

作者信息

Gaudiano Caterina, Braccischi Lorenzo, Taninokuchi Tomassoni Makoto, Paccapelo Alexandro, Bianchi Lorenzo, Corcioni Beniamino, Ciccarese Federica, Schiavina Riccardo, Droghetti Matteo, Giunchi Francesca, Fiorentino Michelangelo, Brunocilla Eugenio, Golfieri Rita

机构信息

Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

出版信息

Front Oncol. 2023 Feb 20;13:1082564. doi: 10.3389/fonc.2023.1082564. eCollection 2023.

DOI:10.3389/fonc.2023.1082564
PMID:36890814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986422/
Abstract

BACKGROUND

To evaluate multiparametric magnetic resonance imaging (mpMRI) parameters, such as TransPA (transverse prostate maximum sectional area), TransCGA (transverse central gland sectional area), TransPZA (transverse peripheral zone sectional area), and TransPAI (TransPZA/TransCGA ratio) in predicting prostate cancer (PCa) in prostate imaging reporting and data system (PI-RADS) 3 lesions.

METHODS

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV), the area under the receiver operating characteristic curve (AUC), and the best cut-off, were calculated. Univariate and multivariate analyses were carried out to evaluate the capability to predict PCa.

RESULTS

Out of 120 PI-RADS 3 lesions, 54 (45.0%) were PCa with 34 (28.3%) csPCas. Median TransPA, TransCGA, TransPZA and TransPAI were 15.4cm, 9.1cm, 5.5cm and 0.57, respectively. At multivariate analysis, location in the transition zone (OR=7.92, 95% CI: 2.70-23.29, P<0.001) and TransPA (OR=0.83, 95% CI: 0.76-0.92, P<0.001) were independent predictors of PCa. The TransPA (OR=0.90, 95% CI: 0.082-0.99, P=0.022) was an independent predictor of csPCa. The best cut-off of TransPA for csPCa was 18 (Sensitivity 88.2%, Specificity 37.2%, PPV 35.7%, NPV 88.9%). The discrimination (AUC) of the multivariate model was 0.627 (95% CI: 0.519-0.734, P<0.031).

CONCLUSIONS

In PI-RADS 3 lesions, the TransPA could be useful in selecting patients requiring biopsy.

摘要

背景

评估多参数磁共振成像(mpMRI)参数,如经前列腺横截面积(TransPA)、经中央腺体横截面积(TransCGA)、经外周带横截面积(TransPZA)和经外周带与中央腺体面积比(TransPAI)在前列腺影像报告和数据系统(PI-RADS)3类病变中预测前列腺癌(PCa)的价值。

方法

计算敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)、受试者操作特征曲线下面积(AUC)以及最佳截断值。进行单因素和多因素分析以评估预测PCa的能力。

结果

120例PI-RADS 3类病变中,54例(45.0%)为PCa,其中34例(28.3%)为临床有意义的前列腺癌(csPCa)。TransPA、TransCGA、TransPZA和TransPAI的中位数分别为15.4cm²、9.1cm²、5.5cm²和0.57。多因素分析显示,移行带位置(OR=7.92,95%CI:2.70-23.29,P<0.001)和TransPA(OR=0.83,95%CI:0.76-0.92,P<0.001)是PCa的独立预测因素。TransPA(OR=0.90,95%CI:0.082-0.99,P=0.022)是csPCa的独立预测因素。csPCa的TransPA最佳截断值为18(敏感性88.2%,特异性37.2%,PPV 35.7%,NPV 88.9%)。多因素模型的鉴别能力(AUC)为0.627(95%CI:0.519-0.734,P<0.031)。

结论

在PI-RADS 3类病变中,TransPA有助于选择需要活检的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/9986422/2687c8e68c63/fonc-13-1082564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/9986422/3fa401084751/fonc-13-1082564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/9986422/2687c8e68c63/fonc-13-1082564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/9986422/3fa401084751/fonc-13-1082564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/9986422/2687c8e68c63/fonc-13-1082564-g002.jpg

相似文献

1
Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging.经多参数磁共振成像检查,前列腺横截面积最大值可预测PI-RADS 3级病变中具有临床意义的前列腺癌。
Front Oncol. 2023 Feb 20;13:1082564. doi: 10.3389/fonc.2023.1082564. eCollection 2023.
2
MRI-Based Nomogram of Prostate Maximum Sectional Area and Its Zone Area for Prediction of Prostate Cancer.基于MRI的前列腺最大截面积及其分区面积预测前列腺癌的列线图
Front Oncol. 2021 Sep 9;11:708730. doi: 10.3389/fonc.2021.708730. eCollection 2021.
3
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.前列腺影像报告和数据系统第 2 版检测临床显著前列腺癌的阳性预测值:系统评价和荟萃分析。
Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25.
4
How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?如何在 PI-RADS v2 评分≤3 的初次活检无前列腺癌的男性中做出临床决策以避免不必要的前列腺筛查?
Int J Clin Oncol. 2020 Jan;25(1):175-186. doi: 10.1007/s10147-019-01524-9. Epub 2019 Aug 31.
5
Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy.结合临床和MRI数据管理PI-RADS 3类病变并减少过度活检。
Transl Androl Urol. 2020 Jun;9(3):1252-1261. doi: 10.21037/tau-19-755.
6
Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.采用结构化方法解决 PI-RADS v2.1 评分与靶向前列腺活检结果之间的差异:提高质量的机会。
Abdom Radiol (NY). 2022 Aug;47(8):2917-2927. doi: 10.1007/s00261-022-03562-w. Epub 2022 Jun 8.
7
Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.哪些临床和影像学特征可预测 PI-RADS 3 病变中的临床显著前列腺癌?高容量学术中心的回顾性研究。
Eur J Radiol. 2019 May;114:92-98. doi: 10.1016/j.ejrad.2019.02.031. Epub 2019 Feb 25.
8
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.前列腺影像报告和数据系统(PI-RADS)评分与指数病变和多灶性、临床显著前列腺癌的相关性。
Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.
9
Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment.采用前列腺影像报告和数据系统第 2 版(PI-RADS v2)检测前列腺癌可以避免不必要的活检和侵袭性治疗。
Asian J Androl. 2018 Sep-Oct;20(5):459-464. doi: 10.4103/aja.aja_19_18.
10
Cutoff Values of Prostate Imaging Reporting and Data System Version 2.1 Score in Men With Prostate-specific Antigen Level 4 to 10 ng/mL: Importance of Lesion Location.前列腺影像报告和数据系统第 2.1 版评分在前列腺特异性抗原水平为 4 至 10ng/mL 男性中的截断值:病变位置的重要性。
Clin Genitourin Cancer. 2021 Aug;19(4):288-295. doi: 10.1016/j.clgc.2020.12.007. Epub 2021 Jan 7.

引用本文的文献

1
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study.评估现有工具在预测双参数磁共振成像显示为不确定病变的男性中具有临床意义的前列腺癌的性能,并开发一种新型多重模型:一项前瞻性队列研究。
EClinicalMedicine. 2025 Apr 3;82:103191. doi: 10.1016/j.eclinm.2025.103191. eCollection 2025 Apr.
2
An Apparent Diffusion Coefficient-Based Machine Learning Model Can Improve Prostate Cancer Detection in the Grey Area of the Prostate Imaging Reporting and Data System Category 3: A Single-Centre Experience.基于表观扩散系数的机器学习模型可改善前列腺影像报告和数据系统3类灰色区域中的前列腺癌检测:单中心经验
Cancers (Basel). 2023 Jun 30;15(13):3438. doi: 10.3390/cancers15133438.

本文引用的文献

1
PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists.PI-RADS 版本 2.1 用于评估移行区病变:放射科医师实用指南。
Br J Radiol. 2022 Mar 1;95(1131):20210916. doi: 10.1259/bjr.20210916. Epub 2022 Feb 11.
2
Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones.评估临床和影像学数据在预测前列腺影像报告和数据系统 2.1 版外周带和移行带 3 类病变前列腺癌中的表现。
Int Urol Nephrol. 2022 Feb;54(2):263-271. doi: 10.1007/s11255-021-03071-7. Epub 2021 Nov 25.
3
Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation.
人工智能辅助前列腺癌诊断:影像学-病理学相关性。
Radiographics. 2021 Oct;41(6):1676-1697. doi: 10.1148/rg.2021210020.
4
MRI-Based Nomogram of Prostate Maximum Sectional Area and Its Zone Area for Prediction of Prostate Cancer.基于MRI的前列腺最大截面积及其分区面积预测前列腺癌的列线图
Front Oncol. 2021 Sep 9;11:708730. doi: 10.3389/fonc.2021.708730. eCollection 2021.
5
Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.MRI/TRUS 融合引导活检与系统前列腺活检在初次活检阴性和接受主动监测的患者中的诊断性能比较。
Minerva Urol Nephrol. 2021 Jun;73(3):357-366. doi: 10.23736/S2724-6051.20.03758-3. Epub 2021 Mar 26.
6
Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.2020 年及以后的前列腺癌早期检测:欧盟和欧盟委员会的事实和建议。
Eur Urol. 2021 Mar;79(3):327-329. doi: 10.1016/j.eururo.2020.12.010. Epub 2020 Dec 29.
7
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
8
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会(ISUP)前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.
9
Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis.实现 MRI 诊断途径在前列腺癌诊断中的临床影响。
Abdom Radiol (NY). 2020 Dec;45(12):4012-4022. doi: 10.1007/s00261-020-02547-x.
10
The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies.前列腺特异性抗原密度对多参数磁共振成像上前列腺影像报告和数据系统3类病变的价值:一种避免不必要前列腺活检的策略
Eur Urol Focus. 2021 Mar;7(2):325-331. doi: 10.1016/j.euf.2019.11.012. Epub 2019 Dec 12.